KIDNEY TRANSPLANT COLLABORATIVE (EIN 862815247) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

LOUIS DIAMOND

Phone

2025081470

Tax Period

2023-01-01 to 2023-12-31

KIDNEY TRANSPLANT COLLABORATIVE, founded in 2021, is a community nonprofit in the Health Care sector that reported $1.0M in total revenue in fiscal year 2023. Revenue surged 85496% from the prior year, signaling strong growth momentum. Expenses of $2.3M exceeded revenue, resulting in a 129% operating deficit.

Mission

KTC IS A NATIONAL NON-PROFIT ADVOCACY ORGANIZATION THAT IS DEDICATED TO INCREASING KIDNEY TRANSPLANTS WHILE DECREASING THE FINANCIAL OBSTACLES AND OTHER CHALLENGES KIDNEY RECIPIENTS, DONORS, AND FAMILIES OFTEN EXPERIENCE DURING THE KIDNEY TRANSPLANTATION PROCESS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,000,000

Program Service Revenue $0

Investment Income $622

Other Revenue $0

TOTAL REVENUE $1,000,622

Expense Breakdown

Grants Paid $1,147,288

Salaries & Benefits $243,000

Fundraising Expenses $0

Program Expenses $1,917,888

Other Expenses $905,112

TOTAL EXPENSES $2,295,400

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,000,622	$1,169	+855.0%
Expenses	$2,295,400	$2,368,116	0.0%
Net Income	$-1,294,778	$-2,366,947	-0.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$228,000

Total Directors

$243,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LOUIS H DIAMOND	PRESIDENT AND CHAIR	10.00	Officer Director	$228,000	$0	$228,000
JOHN C WEINBERG	DIRECTOR	2.00	Director	$5,000	$0	$5,000
NANCY ARMISTEAD	DIRECTOR	2.00	Director	$5,000	$0	$5,000
REBECCA J SCHMIDT	DIRECTOR	2.00	Director	$5,000	$0	$5,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,000,622	$2,295,400	$661,253	$-1,294,778
2022	$1,169	$2,368,116	$1,962,819	$-2,366,947
2021	$5,000,000	$682,022	$4,320,804	$4,317,978

KIDNEY TRANSPLANT COLLABORATIVE